Showing results (3201-3210 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|May 2, 2000
Emerging roles of carbohydrates and glycomimetics in anticancer drug designJ J BarchiCurrent Pharmaceutical Design|May 2, 2000
Anti-HIV-1 integrase drugs: how far from the shelf?A Pani, M E MarongiuCurrent Pharmaceutical Design|May 2, 2000
Design of anti-HIV compounds: from nucleoside to nucleoside 5'-triphosphate analogs. Problems and perspectivesM Kukhanova, A Krayevsky, W Prusoff, et al.Current Pharmaceutical Design|May 2, 2000
Therapeutic use of chemokinesC M Hogaboam, C Bone-Larson, A Matsukawa, et al.Current Pharmaceutical Design|May 2, 2000
Cytokine therapeutics for infectious diseasesF H Rodriguez, S Nelson, J K KollsCurrent Pharmaceutical Design|December 14, 1999
Solid-phase and combinatorial synthesis in beta-lactam chemistryE G MataCurrent Pharmaceutical Design|April 10, 1999
Recent progress in the development of tubulin inhibitors as antimitotic antitumor agentsQ Shi, K Chen, S L Morris-Natschke, et al.Current Pharmaceutical Design|April 10, 1999
Therapeutic approaches to the treatment of neuroinflammatory diseasesS J HaysCurrent Pharmaceutical Design|April 10, 1999
Dopamine-beta-hydroxylase inhibition: a novel sympatho-modulatory approach for the treatment of congestive heart failureS S Hegde, K F FridayCurrent Pharmaceutical Design|March 6, 1999
Therapeutic strategies for coronary artery disease beyond low density lipoprotein (LDL)--loweringY Arad, U SaxenaPageof 1,008